Better TherapeuticsBTTX
13F holders, Q2 2024 (June 30)1holders −2
1new positions
3sold out
$0.01avg. 13F price*
At the end of Q2 2024, 1 institutions reported holding Better Therapeutics Inc. (BTTX) in their 13F filings, down 2 from Q1 2024. 1 opened new positions and 3 sold out. The largest holder was Ancora Advisors LLC ($37).
- Company
- Better Therapeutics Inc.
- CUSIP
- 08773T104
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $37 |
| Exits | 3 | $1K |
All 13F filers, Q1 2024 → Q2 2024: 3,000 shares bought and 103,870 shares sold, net −100,870 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Ancora Advisors LLC | 0.00% | New | 3,000 | $37 |
"% of holder's portfolio" is BTTX's weight in each manager's 13F, not the share of Better Therapeutics Inc. the manager owns.